NCCN指南®洞察:非小细胞肺癌,版本7.202525 洞察
Gregory J Riely1, Douglas E Wood2, Dara L Aisner3
11Memorial Sloan Kettering Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|September 10, 2025
概括
更新了NCCN关于非小细胞肺癌 (NSCLC) 的指导方针,以专注于非转移性NSCLC的系统治疗. 这些更新包括用于指导治疗决策的分子测试建议.
科学领域:
- 在瘤学瘤学.
- 临床指南 临床指南
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症相关死亡的主要原因之一.
- 目前NSCLC的治疗策略正在发展,需要更新的临床指导.
研究的目的:
- 总结国家综合癌症网络 (NCCN) 关于NSCLC的指导方针的最新更新.
- 突出非转移性NSCLC患者的全身治疗选择.
- 讨论与这些治疗更新相关的分子测试考虑.
主要方法:
- 审查最新的NCCN关于NSCLC的指导方针.
- 对NCCN指南的分析 关注最近的修订的洞察力.
- 对非转移性NSCLC的系统疗法和分子测试信息的综合.
主要成果:
- 最近的NCCN指南提供了针对非转移性NSCLC的全身治疗的最新建议.
- 强调了特定的分子测试策略,以告知治疗选择.
- 这些指导方针涉及将新的治疗方法纳入临床实践.
结论:
- 更新的NCCN指南为管理非转移性NSCLC提供了关键的见解.
- 坚持推的全身疗法和分子测试可以优化患者的治疗结果.
- 这些指南是治疗NSCLC的瘤学家的重要资源.
更多相关视频
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
352
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Standards of Care II
1.0K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.0K
Standards of Care I
1.1K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.1K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
